<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Outcomes associated with nocturnal hemodialysis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Outcomes associated with nocturnal hemodialysis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Outcomes associated with nocturnal hemodialysis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jennifer E Flythe, MD, MPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Steve J Schwab, MD, FACP, FASN</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Eric N Taylor, MD, MSc, FASN</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Nov 08, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3300247863"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The mortality rate of patients undergoing maintenance hemodialysis is unacceptably high [<a href="#rid1">1</a>]. An extremely high morbidity, relatively low quality of life (due in part to a high level of dependence and unemployment), and high cost have also been observed.</p><p>The Hemodialysis (HEMO) and Adequacy of Peritoneal Dialysis in Mexico (ADEMEX) trials found that increasing the dialysis dose within the general restrictions of a three-times-weekly regimen or of peritoneal dialysis, respectively, failed to decrease patient mortality [<a href="#rid2">2-5</a>] (see  <a class="medical medical_review" href="/z/d/html/1847.html" rel="external">"Patient survival and maintenance dialysis"</a> and  <a class="medical medical_review" href="/z/d/html/1836.html" rel="external">"Prescribing and assessing adequate hemodialysis"</a>). The institution of more intensive dialysis regimens provided evidence of improvement in morbidity and possible mortality in this patient population. Compared with conventional three-times-per-week regimens, for example, dialysis associated with longer duration and/or higher frequency correlated with enhanced outcomes [<a href="#rid6">6-9</a>].</p><p>Nocturnal hemodialysis was introduced as a (possibly) more desirable alternative to conventional dialysis since it provides superior dialysis based upon dose, duration, and, for home nocturnal dialysis, frequency. This can be accomplished because it is performed during sleep. Nocturnal dialysis regimens consist of either long (eg, six to eight hours) thrice-weekly dialysis sessions administered in-center, or long and frequent (eg, four to six days per week) dialysis sessions administered at home. Because of this variability, caution must be applied when interpreting outcomes data comparing nocturnal with conventional hemodialysis.</p><p>This topic will review the outcomes associated with nocturnal hemodialysis. Technical aspects of nocturnal hemodialysis and an overview of short daily hemodialysis are presented separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1904.html" rel="external">"Technical aspects of nocturnal hemodialysis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1898.html" rel="external">"Short daily hemodialysis"</a>.)</p><p></p><p class="headingAnchor" id="H198206382"><span class="h1">OVERVIEW</span><span class="headingEndMark"> — </span>Several observational and cohort studies have shown that nocturnal hemodialysis is associated with marked benefits compared with conventional hemodialysis regimens. These include improved solute clearance, possibly improved quality of life, better blood pressure control and other cardiovascular benefits, reduced medication requirements, and decreased hospitalization and mortality rates. Some of these benefits have not been confirmed in randomized controlled trials and should be interpreted with caution, since patients receiving nocturnal hemodialysis tend to be younger, healthier [<a href="#rid10">10</a>], and have a higher functional status [<a href="#rid11">11</a>] than patients receiving conventional thrice-weekly hemodialysis. It should also be noted that while the majority of studies were performed using conventional hemodialysis machines with high dialysate flows, most of the home hemodialysis patients in the United States use low dialysate flow machines (eg, NxStage) [<a href="#rid12">12</a>].</p><p>Multiple observational studies and two randomized trials have shown that more frequent dialysis improves selected outcomes. A benefit on survival has not been convincingly shown. These data are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/1898.html" rel="external">"Short daily hemodialysis", section on 'Outcomes'</a>.)</p><p class="headingAnchor" id="H2014877068"><span class="h1">SOLUTE CLEARANCE</span><span class="headingEndMark"> — </span>Clearance of different solutes is markedly enhanced with nocturnal hemodialysis.</p><p class="headingAnchor" id="H1876889561"><span class="h2">Urea</span><span class="headingEndMark"> — </span>Even at low dialysate flow rates (100 mL/min), nocturnal hemodialysis can provide a nightly equilibrated Kt/V for urea of approximately 1 [<a href="#rid13">13,14</a>]. Higher dialysate flows in combination with large surface area dialyzers provide a single-pool Kt/V of 1.7 to 2 [<a href="#rid15">15,16</a>]. The weekly standard Kt/V, which allows for comparison of the dialysis dose across dissimilar regimens [<a href="#rid17">17</a>], is approximately 5 for a dialysis prescription of eight hours six nights per week [<a href="#rid16">16,18</a>]. Such values are substantially higher than the minimum thresholds of Kt/V suggested by <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.kidney.org%2Fprofessionals%2Fguidelines%2Fhemodialysis2015&amp;token=pP%2FoQ7lfs1lNfklnem%2FBY3Q%2Fguv37oL2nuUR72wy1FaiShQ2bSpVj8yk0sitsv34Sisn%2FcieQXRxz%2BDJvMX8zEN6f2NItsx880imy7yDo9M%3D&amp;TOPIC_ID=1959" target="_blank">the Kidney Disease Outcomes Quality Initiative (KDOKQI) guidelines</a> [<a href="#rid19">19</a>].</p><p class="headingAnchor" id="H4101343583"><span class="h2">Phosphate</span><span class="headingEndMark"> — </span>Weekly removal of phosphate with nocturnal hemodialysis is higher compared with conventional hemodialysis, thereby obviating the need for phosphate binders in many patients [<a href="#rid13">13,20-26</a>]. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>In the Frequent Hemodialysis Network (FHN) Nocturnal trial, 87 patients were randomly assigned to either three-times-weekly conventional hemodialysis or six-times-weekly nocturnal hemodialysis [<a href="#rid27">27</a>]. At 12 months of follow-up, patients receiving frequent nocturnal hemodialysis, compared with those receiving conventional hemodialysis, had a lower serum phosphate (4.72 versus 5.91 mg/dL, respectively), and many more patients did not require phosphate binders (73 percent versus 8 percent in the conventional hemodialysis group) [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a crossover study, the serum phosphate levels of eight patients on chronic dialysis were measured during five months of conventional hemodialysis and then after the switch to five months of therapy with nocturnal hemodialysis [<a href="#rid20">20</a>]. Serum phosphate levels were significantly lower with nocturnal hemodialysis (4.0 versus 6.5 mg/dL [1.3 versus 2.1 mmol/L]) than with conventional hemodialysis. In addition, patients undergoing nightly dialysis increased their dietary phosphate intake by 50 percent and did not require phosphate binders after the fourth month. Furthermore, to maintain normal serum phosphate concentrations, more than 50 percent of all patients required the addition of phosphate to the dialysate.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a study of 26 patients who were converted from home hemodialysis (three to five hours, 3.5 to 4 sessions weekly) to every-other-night home hemodialysis (six to nine hours, 3.5 to 4 sessions weekly), the number of patients requiring phosphate binders decreased from 92.3 percent at baseline to 22.8 percent [<a href="#rid28">28</a>].</p><p></p><p>As phosphate removal is dialysis time dependent, the NxStage machine, despite its low dialysate flow, increases phosphate removal during nocturnal hemodialysis [<a href="#rid29">29</a>].</p><p class="headingAnchor" id="H44034210"><span class="h2">Beta2-microglobulin</span><span class="headingEndMark"> — </span>Since large molecule removal by hemodialysis is time dependent, the removal of beta2-microglobulin is markedly higher with nocturnal hemodialysis than with conventional hemodialysis. In one study, nocturnal hemodialysis administered six nights per week was associated with a four-times-higher solute removal of beta2-microglobulin (585 versus 127 mg/week) and a greater reduction in plasma beta2-microglobulin concentrations (39 versus 21 percent) compared with conventional hemodialysis (performed for four hours, three times per week) [<a href="#rid30">30</a>]. Although unproven, this finding may be associated with a delay in the development of dialysis-related amyloidosis.</p><p class="headingAnchor" id="H349843527"><span class="h1">SURVIVAL</span><span class="headingEndMark"> — </span>Studies evaluating patient survival on nocturnal hemodialysis have yielded conflicting results [<a href="#rid10">10,31-37</a>]. While several observational studies have shown a possible survival benefit compared with conventional hemodialysis, other studies including one randomized trial have not confirmed these findings. The following studies illustrate the range of findings:</p><p class="bulletIndent1"><span class="glyph">●</span>Among 746 patients initiated for the first time on in-center, three-times-weekly nocturnal hemodialysis performed at 77 outpatient centers in the United States, the two-year adjusted mortality risk was lower compared with 2062 matched control patients on conventional hemodialysis (19 versus 27 percent, respectively, hazard ratio [HR] 0.75, 95% CI 0.61-0.91) [<a href="#rid10">10</a>]. The mortality of the matched cohort was lower than the reported mortality rate for hemodialysis patients in the United States, however, suggesting that patients selected for in-center nocturnal hemodialysis may be healthier than the average hemodialysis patient in the United States [<a href="#rid38">38</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In one retrospective study, 338 patients who were receiving intensive home hemodialysis (either day or overnight with a mean of 4.8 sessions per week and a mean treatment time of 7.4 hours per session) were compared with 1338 propensity-matched patients on conventional hemodialysis (mean of three sessions per week with a mean treatment time of 7.4 hours per session) [<a href="#rid34">34</a>]. Mortality was lower among patients on intensive hemodialysis (13 versus 21 percent for control patients on conventional hemodialysis).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A matched cohort study reported that mortality was significantly lower among 94 patients undergoing nocturnal hemodialysis compared with 43 patients undergoing thrice-weekly conventional hemodialysis (HR 0.38, 95% CI 0.22-0.61) [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A retrospective, matched cohort study found similar survival rates in a Canadian cohort of patients undergoing nocturnal hemodialysis and an American deceased-donor transplantation cohort [<a href="#rid31">31</a>]. In a similar study that included a Canadian rather than an American patient transplantation cohort, the nocturnal hemodialysis patient survival rate was inferior to the diseased-donor cohort. This reflected the difference in mortality between the two transplant cohorts rather than the nocturnal hemodialysis groups [<a href="#rid35">35</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the Frequent Hemodialysis Network (FHN) Nocturnal trial, which randomly assigned 87 patients to either three-times-weekly conventional hemodialysis or six-times-weekly nocturnal hemodialysis, there was no difference between the groups at 12 months in the two primary composite endpoints, which included death or change in left ventricular mass and death or change in quality of life as assessed by the RAND-36 survey [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1">A follow-up study of the patients after the completion of the FHN trial showed a higher mortality rate in the nocturnal hemodialysis group compared with controls dialyzed mainly on conventional home hemodialysis [<a href="#rid33">33</a>]. The deaths took place mainly during the year after the completion of the trial. The results were unexpected and contradict the data from the observational studies. It should be noted that the mortality rate of the control group was surprisingly low, the sample size was small, and there was a high rate of hemodialysis prescription change after the completion of the study [<a href="#rid39">39</a>].</p><p></p><p class="headingAnchor" id="H912665879"><span class="h1">QUALITY OF LIFE</span><span class="headingEndMark"> — </span>Among those treated with and/or switched to nocturnal hemodialysis, there are improvements in some, but not all, parameters [<a href="#rid27">27,40-46</a>]. The improvement in the quality of life was not confirmed in two prospective, randomized, controlled trials [<a href="#rid42">42,47</a>], although some of the kidney-disease-specific quality-of-life domain parameters improved in one study [<a href="#rid42">42</a>]. Both trials may have been underpowered to show a possible benefit [<a href="#rid27">27,48</a>].</p><p>Using different methodologies to determine patient preference, patients appear to prefer nocturnal hemodialysis to conventional in-center hemodialysis [<a href="#rid49">49</a>].</p><p class="headingAnchor" id="H4267702911"><span class="h1">CARDIOVASCULAR EFFECTS</span></p><p class="headingAnchor" id="H1329411347"><span class="h2">Blood pressure</span><span class="headingEndMark"> — </span>Excellent blood pressure control is achieved by nocturnal hemodialysis, with many patients no longer requiring antihypertensive medications. As an example, in the Frequent Hemodialysis Network (FHN) Nocturnal trial, systolic blood pressure was lower at 12 months among patients who received frequent nocturnal dialysis compared with those who received conventional three-times-weekly hemodialysis (137 versus 151 mmHg, respectively) [<a href="#rid27">27,50</a>]. A meta-analysis of 21 studies that included over 1000 patients on in-center nocturnal hemodialysis and over 15,000 patients on conventional three-times-weekly hemodialysis reported that nocturnal hemodialysis was associated with a 3.2 mmHg decrease in systolic blood pressure [<a href="#rid26">26</a>].</p><p>To achieve normotension without medications, the target weight is progressively decreased until all antihypertensive agents are discontinued [<a href="#rid15">15,51</a>].</p><p class="headingAnchor" id="H1268666241"><span class="h2">Left ventricular hypertrophy</span><span class="headingEndMark"> — </span>Some, but not all, studies suggest that nocturnal hemodialysis is associated with regression of left ventricular hypertrophy [<a href="#rid15">15,22,27</a>]. As an example, in a study of 44 patients undergoing maintenance hemodialysis who were randomly assigned to nocturnal hemodialysis (six times/week) or continued conventional hemodialysis (three times/week) [<a href="#rid22">22</a>], at six months, left ventricular mass had significantly decreased with nocturnal hemodialysis (177 to 164 g) compared with no change in the conventional hemodialysis group (182 to 183 g). The effect was related, in part, to a decrease in blood pressure; however, the effect of improved volume control was unclear since volume status was not assessed.</p><p>However, in the FHN Nocturnal trial, despite a positive trend, there was no difference at 12 months in one of the primary composite endpoints, which included death or change in left ventricular mass, among 87 patients who were randomly assigned to either three-times-weekly conventional hemodialysis or six-times-weekly nocturnal hemodialysis [<a href="#rid27">27</a>].</p><p>Left as well as right ventricular remodeling have been reported in patients on three-times-weekly nocturnal hemodialysis [<a href="#rid52">52-54</a>]. One small study suggested a potential mechanistic role for fibroblast growth factor 23 (FGF23), showing improvements in echocardiographic parameters, reduction in left ventricular hypertrophy, and lower levels of circulating FGF23 when patients were converted from conventional three-times-weekly hemodialysis to in-center nocturnal hemodialysis [<a href="#rid55">55</a>].</p><p class="headingAnchor" id="H3616621474"><span class="h2">Cardiac function</span><span class="headingEndMark"> — </span>Limited evidence suggests that the switch to nocturnal hemodialysis may improve myocardial function as assessed by ejection fraction. In one small study, for example, cardiac function improved upon conversion to frequent nocturnal hemodialysis in a group of six patients with end-stage kidney disease (ESKD) and diminished left ventricular ejection fraction [<a href="#rid56">56</a>]. Ejection fraction increased from 28 to 41 percent. In another study, intradialytic left ventricular regional wall motion abnormalities (myocardial stunning) decreased with increasing dialysis intensity, favoring daily and frequent nocturnal hemodialysis [<a href="#rid57">57</a>]. Myocardial stunning is associated with high ultrafiltration requirements, intradialytic hypotension, long-term loss of systolic function, increased likelihood of cardiovascular events, and death [<a href="#rid57">57</a>].</p><p class="headingAnchor" id="H4066886551"><span class="h2">Vascular function</span><span class="headingEndMark"> — </span>There are improvements in vascular responsiveness with nocturnal hemodialysis. In a prospective cohort study of 18 patients with ESKD before and after conversion to frequent nocturnal hemodialysis, an improvement in blood pressure control was associated with significant decreases in the total peripheral resistance (TPR) [<a href="#rid58">58</a>]. This suggests that the hypotensive effect of nocturnal hemodialysis is mediated through a reduction in an elevated TPR rather than exclusively by a fall in the intravascular volume [<a href="#rid58">58</a>]. Other studies have shown increased vascular compliance, improved endothelium-dependent vasodilatation, increased number and function of endothelial progenitor cells, improved angiogenesis, and restoration of perfusion associated with nocturnal hemodialysis [<a href="#rid59">59-61</a>].</p><p class="headingAnchor" id="H550347288"><span class="h2">Heart rate variability</span><span class="headingEndMark"> — </span>Conversion from conventional to frequent nocturnal hemodialysis is associated with increased heart rate variability during sleep [<a href="#rid62">62</a>]. The FHN Nocturnal trial also detected beneficial effects of daily hemodialysis in the form of increased vagal modulation and increased beat-to-beat variation [<a href="#rid63">63</a>] (see  <a class="medical medical_review" href="/z/d/html/1898.html" rel="external">"Short daily hemodialysis", section on 'Frequent Hemodialysis Network (FHN) daily trial'</a>). A decrease in heart rate variability, a characteristic common in patients with ESKD, correlates with increased cardiovascular mortality in the general population [<a href="#rid64">64</a>]. How this affects clinical outcomes needs to be determined. Nocturnal hemodialysis has also been associated with improved baroreflex sensitivity and the baroreflex effectiveness index [<a href="#rid65">65</a>].</p><p class="headingAnchor" id="H3102895640"><span class="h2">Coronary calcification</span><span class="headingEndMark"> — </span>The natural history of coronary calcification and factors underlying progression were evaluated in an observational cohort study of 38 patients who converted to frequent nocturnal dialysis [<a href="#rid66">66</a>]. At follow-up at a mean of 16 months, there was no change in coronary calcification (as assessed by multislice computed tomography [CT]) in 24 patients with minimal coronary calcification (initial score of 0.7 to follow-up score of 6.0), while there was a nonsignificant increase in the remaining individuals with higher initial calcification (1874 to 2038). The calcium-phosphate product and use of oral calcium-based phosphate binders also significantly decreased after conversion.</p><p>This rate of coronary calcification progression is significantly lower than that observed in studies of patients undergoing conventional hemodialysis and peritoneal dialysis. Although further study with a randomized, controlled trial is required, these findings suggest that conversion to nocturnal hemodialysis may lower rates of progression of coronary calcification, perhaps due in part to favorable effects upon calcium/phosphate metabolism. (See  <a class="medical medical_review" href="/z/d/html/7222.html" rel="external">"Vascular calcification in chronic kidney disease"</a>.)</p><p class="headingAnchor" id="H1080479328"><span class="h1">ANEMIA</span><span class="headingEndMark"> — </span>Several reports claiming improved anemia control on daily or nocturnal hemodialysis have been published [<a href="#rid67">67,68</a>]. However, negative results have also been reported [<a href="#rid13">13,27,69</a>].</p><p>In one study, 63 patients on frequent nocturnal hemodialysis and 32 self-care patients on dialysis were evaluated with respect to anemia control [<a href="#rid70">70</a>]. After conversion to nocturnal hemodialysis, there was a substantial increase in hemoglobin concentrations with a fall in recombinant human erythropoietin (rHuEPO) requirements, while the control cohort did not reflect such changes [<a href="#rid70">70</a>]. There were no differences in baseline iron indices between the two groups. In addition to these decreased requirements, approximately 24 percent of patients on nocturnal hemodialysis versus 9 percent of controls no longer required the administration of rHuEPO [<a href="#rid18">18,70</a>]. The effect of nocturnal hemodialysis on erythropoiesis needs further investigation.</p><p>There was no increase in hemoglobin or decrease in the rHuEPO dose associated with nocturnal hemodialysis in the Frequent Hemodialysis Network (FHN) Nocturnal trial [<a href="#rid71">71</a>].</p><p>A meta-analysis of 21 studies that included over 1000 patients on in-center nocturnal hemodialysis and over 15,000 patients on conventional three-times-weekly hemodialysis reported that nocturnal hemodialysis was associated with a 0.5 g/dL increase in hemoglobin level [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H403339093"><span class="h1">BONE MINERAL METABOLISM</span><span class="headingEndMark"> — </span>The excellent phosphate control on nocturnal hemodialysis is useful in the prevention and treatment of secondary hyperparathyroidism. High dialysate calcium levels suppress parathyroid hormone (PTH) levels successfully and normalize alkaline phosphatase levels in most patients [<a href="#rid72">72</a>]. This is achieved by adjusting the dialysate calcium. Inadequate dialysate calcium can lead to negative calcium balance associated with increased PTH and alkaline phosphatase [<a href="#rid73">73,74</a>]. Conversely, an overzealous increase in dialysate calcium can lead to low bone turnover [<a href="#rid72">72</a>] or promote vascular calcifications.</p><p>Bone density studies can be useful in adjusting dialysate calcium concentrations and ensuring that negative calcium balance is avoided. The role of vitamin D analogs is unknown. In one patient, extensive preexisting extraosseous tumoral calcifications dissolved upon conversion to nocturnal hemodialysis [<a href="#rid75">75</a>].</p><p>There is also an increase in both 25-hydroxy and 1,25-dihydroxy vitamin D levels, which directly correlates with the enhanced dialysis dose in nocturnal hemodialysis [<a href="#rid76">76</a>]. The clinical significance of increased vitamin D levels is unclear.</p><p class="headingAnchor" id="H3944097550"><span class="h1">DYSLIPIDEMIA</span><span class="headingEndMark"> — </span>Chronic kidney disease, including end-stage kidney disease (ESKD), is associated with significant dyslipidemia. This commonly consists of increased levels of triglycerides, total cholesterol, low-density lipoproteins (LDL), non-high-density lipoproteins (HDL), and reduced HDL. (See  <a class="medical medical_review" href="/z/d/html/7204.html" rel="external">"Lipid management in patients with nondialysis chronic kidney disease"</a> and  <a class="medical medical_review" href="/z/d/html/3114.html" rel="external">"Lipid abnormalities in nephrotic syndrome"</a>.)</p><p>Nocturnal hemodialysis may improve the lipid profile of patients with ESKD. This was reported in a study of 11 patients undergoing conventional hemodialysis in whom decreases in triglyceride levels (186 to 89 mg/dL [2.1 to 1.0 mmol/L]) and increases in HDL levels (45 to 64 mg/dL [1.17 to 1.65 mmol/L]) occurred after three months of frequent nocturnal hemodialysis [<a href="#rid77">77</a>]. Total cholesterol and LDL levels were unchanged.</p><p class="headingAnchor" id="H3840323692"><span class="h1">SLEEP</span><span class="headingEndMark"> — </span>Sleep disturbance is minimal during home nocturnal hemodialysis, and sleep architecture appears to improve [<a href="#rid78">78</a>]. In one study, for example, assessment of sleep performed before and after the conversion to nocturnal hemodialysis found that the new regimen significantly improved preexisting sleep apnea [<a href="#rid79">79</a>]. In seven patients, conversion was associated with a markedly decreased number of apnea and hypopnea episodes (46 to 9 per hour) and increased oxygen saturation (89.2 to 94.1 percent). However, periodic limb movements and daytime sleepiness do not improve on nocturnal hemodialysis [<a href="#rid80">80</a>]. (See  <a class="medical medical_review" href="/z/d/html/16197.html" rel="external">"Sleep disorders in end-stage kidney disease", section on 'Sleep apnea'</a>.)</p><p class="headingAnchor" id="H2736887476"><span class="h1">NUTRITION</span><span class="headingEndMark"> — </span>Nocturnal hemodialysis usually allows patients to liberalize their dietary intake. Most patients on nocturnal hemodialysis can be maintained on a free diet, including the unrestricted intake of salt, water, potassium, phosphate, and protein.</p><p>Although potassium intake is not restricted, the amount ingested needs to be relatively consistent. The potassium dialysate concentration is adjusted as necessary.</p><p>A high protein intake is encouraged as patients on nocturnal hemodialysis lose 10 to 15 g of amino acids daily in the dialysate [<a href="#rid81">81</a>].</p><p>Serum albumin did not change after a year on frequent nocturnal hemodialysis [<a href="#rid13">13</a>]. Conversely, one study detected a decrease in serum albumin on nocturnal hemodialysis not observed on short daily hemodialysis [<a href="#rid82">82</a>]. A secondary analysis of data from the Frequent Hemodialysis Network (FHN) trial cited above showed no difference between patients undergoing frequent nocturnal versus conventional hemodialysis in serum albumin, protein catabolic rate, or total body weight at 12 months [<a href="#rid83">83</a>]. Further studies are needed to delineate the effect of nocturnal hemodialysis on nutrition.</p><p>The dose of daily multivitamin preparation is increased to two tablets daily. However, there has been no definite evidence of vitamin deficiency [<a href="#rid84">84</a>].</p><p class="headingAnchor" id="H731978485"><span class="h1">FERTILITY/PREGNANCY</span><span class="headingEndMark"> — </span>Females undergoing conventional hemodialysis have markedly decreased fertility. When pregnancy does occur, intrauterine growth retardation and miscarriage can occur unless dialysis frequency is increased to five to six times per week. (See  <a class="medical medical_review" href="/z/d/html/117110.html" rel="external">"Pregnancy in patients on dialysis", section on 'Obstetric outcomes'</a>.)</p><p>A paucity of data exists concerning the effect of nocturnal hemodialysis on fertility and pregnancy:</p><p class="bulletIndent1"><span class="glyph">●</span>In a small cohort study, five females undergoing frequent nocturnal hemodialysis had seven pregnancies, resulting in six live infants [<a href="#rid85">85</a>]. Although less common or severe than in historic controls, complications included intrauterine growth restriction or small for gestational age (two infants), delivery before 32 weeks (one), and shortened cervix threatening labor (one). Thus, nocturnal hemodialysis may be associated with improved fertility. However, these findings are limited given the study's small size and observational design. Whether it is the increased frequency, greater dose, or better-timed average concentration of urea that produces a greater success rate requires further prospective studies.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study compared the pregnancy outcomes from 22 pregnancies in the Toronto Pregnancy and Kidney Disease Clinic and Registry (2000 to 2013), including mostly women on intensive hemodialysis, with outcomes from 70 pregnancies in the American Registry for Pregnancy in Dialysis Patients (1990 to 2011). The live birth rate in the Toronto cohort was significantly higher than the rate in the American cohort (86.4 versus 61.4 percent, respectively) [<a href="#rid86">86</a>]. A dose response between dialysis intensity and pregnancy outcomes was shown, with live birth rates of 48 percent in women dialyzed ≤20 hours per week and 85 percent in women dialyzed &gt;36 hours per week.</p><p></p><p>A more detailed discussion of pregnancy in patients on dialysis is presented separately. (See  <a class="medical medical_review" href="/z/d/html/117110.html" rel="external">"Pregnancy in patients on dialysis"</a>.)</p><p class="headingAnchor" id="H3995508364"><span class="h1">COGNITION</span><span class="headingEndMark"> — </span>Nocturnal hemodialysis may be associated with improved general cognitive efficiency as measured by psychomotor efficiency and increased attention and working memory [<a href="#rid87">87</a>], although this has not been shown in all studies [<a href="#rid27">27,88</a>].</p><p class="headingAnchor" id="H491995106"><span class="h1">COST</span><span class="headingEndMark"> — </span>Due to the frequent schedule with daily nocturnal hemodialysis, the cost of consumables is higher than on conventional hemodialysis and is similar to the cost of short daily hemodialysis. On the other hand, the personnel cost of nocturnal hemodialysis at home is lower than with in-center hemodialysis regimens [<a href="#rid89">89</a>].</p><p>Depending upon the consumable/personnel cost ratio in different countries, nocturnal hemodialysis can be less or more expensive than in-center conventional hemodialysis. In addition, the cost of medications, possibly including erythropoietin (EPO; not confirmed in randomized, controlled studies), antihypertensive agents, and phosphate binders, is lower with nocturnal hemodialysis. It also appears that hospitalization expenses may be lower [<a href="#rid40">40,90</a>].</p><p>Two prospective, nonrandomized, controlled studies evaluated the costs associated with home nocturnal versus conventional in-center hemodialysis in Canada [<a href="#rid90">90,91</a>]. The overall treatment cost of patients on nocturnal hemodialysis was 20 percent lower than those on conventional hemodialysis, similar to the observations in a study in the United States [<a href="#rid40">40</a>].</p><p>The combination of improved quality of life and lower cost lead to higher cost utility for nocturnal hemodialysis when compared with conventional hemodialysis [<a href="#rid92">92,93</a>]. A decision analysis that compared nocturnal with conventional hemodialysis based upon a Markov state transition model reported similar findings [<a href="#rid94">94</a>].</p><p class="headingAnchor" id="H1660574184"><span class="h1">POSSIBLE NEGATIVE EFFECTS</span></p><p class="headingAnchor" id="H1313906342"><span class="h2">Vascular access complications</span><span class="headingEndMark"> — </span>There may be more vascular access complications associated with frequent nocturnal hemodialysis compared with conventional three-times-weekly dialysis, as shown in the Frequent Hemodialysis Network (FHN) Nocturnal trial [<a href="#rid27">27</a>]. This may be the result of more frequent arteriovenous access cannulation, although other causes need to be investigated further.</p><p class="headingAnchor" id="H1085496920"><span class="h2">Residual kidney function</span><span class="headingEndMark"> — </span>There may be more rapid decline in residual kidney function in patients on nocturnal hemodialysis compared with conventional three-times-weekly dialysis [<a href="#rid95">95</a>]. This may be the result of decrements in kidney perfusion arising from enhanced fluid removal, although other causes need to be investigated further.</p><p class="headingAnchor" id="H2530906677"><span class="h2">Caregiver burden</span><span class="headingEndMark"> — </span>There may be a higher degree of caregiver burden associated with nocturnal hemodialysis compared with conventional three-times-weekly hemodialysis [<a href="#rid96">96</a>].</p><p class="headingAnchor" id="H3879411550"><span class="h1">ROLE FOR NOCTURNAL HEMODIALYSIS</span><span class="headingEndMark"> — </span>In view of the positive clinical results, acceptance by patients, and favorable financial profile in some jurisdictions, nocturnal home hemodialysis should be considered for patients capable of performing home hemodialysis, and in-center nocturnal hemodialysis should be considered for patients who have access to such programs. Patients with significant metabolic needs including hyperphosphatemia, fluid gains, cardiac dysfunction, resistant hypertension, as well as pregnancy are particularly well suited.</p><p>Patients who would prefer night dialysis to improve quality of life and/or pursue daytime employment or vocational rehabilitation should be considered as well.</p><p>Nocturnal home hemodialysis along with short daily hemodialysis will hopefully increase the use of home hemodialysis. (See  <a class="medical medical_review" href="/z/d/html/1874.html" rel="external">"Choosing home hemodialysis for end-stage kidney disease"</a>.)</p><p>Obstacles to adoption of nocturnal hemodialysis are unfamiliarity with home hemodialysis, the financial impact of the high frequency of dialysis, and the lack of in-center nocturnal programs in some regions. With most current reimbursement schemes, the dialysis provider does <strong>not</strong> benefit from the savings realized from the decreased cost of medications, hospitalization, and transportation but is burdened by the increased cost of providing dialysis at increased frequency [<a href="#rid18">18</a>]. Thus, changes in the reimbursement schemes are needed. The barriers to nocturnal hemodialysis are largely similar to the barriers to home hemodialysis in general [<a href="#rid97">97-100</a>]. Efforts in the form of the Kidney Health Initiative and the Advancing American Kidney Health Initiative in the United States will have a positive effect on the adoption of home dialysis in general [<a href="#rid101">101-104</a>].</p><p class="headingAnchor" id="H3835473593"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes with nocturnal hemodialysis </strong>– Nocturnal hemodialysis appears to be associated with benefits compared with conventional hemodialysis regimens. Some of the benefits with the technique have been clearly shown, while others require further analysis.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Solute clearance </strong>– Clearance of urea, phosphate, and beta2-microglobulin are enhanced with nocturnal hemodialysis. (See <a class="local">'Solute clearance'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Survival </strong>– Studies evaluating patient survival on nocturnal hemodialysis have yielded conflicting results. While several observational studies have shown a possible survival benefit compared with conventional hemodialysis, other studies including one randomized trial have not confirmed these findings. (See <a class="local">'Survival'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Quality of life </strong>– Limited data suggest that quality of life may be improved, although this has not been confirmed by randomized, controlled trials. (See <a class="local">'Quality of life'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiovascular effects </strong>– Excellent blood pressure control is achieved by nocturnal hemodialysis, with many patients no longer requiring antihypertensive medications. Increasing evidence also suggests that nocturnal hemodialysis is associated with regression of left ventricular hypertrophy. (See <a class="local">'Cardiovascular effects'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Sleep and nutrition</strong> – Sleep disturbance is minimal during home nocturnal hemodialysis, and sleep architecture appears to improve. Nocturnal hemodialysis usually allows patients to liberalize their dietary intake. Most patients on nocturnal hemodialysis can be maintained on a free diet, including the unrestricted intake of salt, water, potassium, phosphate, and protein. (See <a class="local">'Sleep'</a> above and <a class="local">'Nutrition'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cost </strong>– Depending upon the consumable/personnel cost ratio in different countries, nocturnal hemodialysis can be less or more expensive than in-center conventional hemodialysis. (See <a class="local">'Cost'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Possible negative effects </strong>– Possible negative effects of frequent nocturnal hemodialysis include increased vascular access complications associated with the higher dialysis frequency, accelerated decline in residual kidney function, and increased caregiver burden. (See <a class="local">'Possible negative effects'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Role for nocturnal hemodialysis </strong>– In view of the clinical results, acceptance by patients, and favorable financial profile in some jurisdictions, nocturnal hemodialysis should be considered as an attractive option for patients who have access to centers equipped to deliver nocturnal hemodialysis via either home or in-center programs. Obstacles to adoption of nocturnal hemodialysis are unfamiliarity with home hemodialysis, the financial impact of the high frequency of dialysis, and the lack of in-center nocturnal programs in some regions. (See <a class="local">'Role for nocturnal hemodialysis'</a> above.)</p><p></p><p class="headingAnchor" id="H3346035656"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>We are saddened by the death of Andreas Pierratos, MD, FRCPC, who passed away in November 2022. UpToDate acknowledges Dr. Pierratos's past work as an author for this topic.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li class="breakAll">United States Renal Data System. 2020 Annual Report. Available at: https://adr.usrds.org/2020/end-stage-renal-disease/5-mortality (Accessed on December 02, 2021).</li><li><a class="nounderline abstract_t">Lowrie EG, Laird NM, Parker TF, Sargent JA. Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 1981; 305:1176.</a></li><li><a class="nounderline abstract_t">Hakim RM, Breyer J, Ismail N, Schulman G. Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 1994; 23:661.</a></li><li><a class="nounderline abstract_t">Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002; 347:2010.</a></li><li><a class="nounderline abstract_t">Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002; 13:1307.</a></li><li><a class="nounderline abstract_t">Saran R, Bragg-Gresham JL, Levin NW, et al. Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 2006; 69:1222.</a></li><li><a class="nounderline abstract_t">Charra B, Calemard E, Ruffet M, et al. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41:1286.</a></li><li><a class="nounderline abstract_t">Buoncristiani U. Fifteen years of clinical experience with daily haemodialysis. Nephrol Dial Transplant 1998; 13 Suppl 6:148.</a></li><li><a class="nounderline abstract_t">Miller BW, Himmele R, Sawin DA, et al. Choosing Home Hemodialysis: A Critical Review of Patient Outcomes. Blood Purif 2018; 45:224.</a></li><li><a class="nounderline abstract_t">Lacson E Jr, Xu J, Suri RS, et al. Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol 2012; 23:687.</a></li><li><a class="nounderline abstract_t">Wilk AS, Tang Z, Hoge C, et al. Association between patient psychosocial characteristics and receipt of in-center nocturnal hemodialysis among prevalent dialysis patients. Hemodial Int 2019; 23:479.</a></li><li><a class="nounderline abstract_t">Leypoldt JK, Weinhandl ED, Collins AJ. Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis. Hemodial Int 2019; 23:42.</a></li><li><a class="nounderline abstract_t">Pierratos A, Ouwendyk M, Francoeur R, et al. Nocturnal hemodialysis: three-year experience. J Am Soc Nephrol 1998; 9:859.</a></li><li><a class="nounderline abstract_t">Powell JR, Oluwaseun O, Woo YM, et al. Ten years experience of in-center thrice weekly long overnight hemodialysis. Clin J Am Soc Nephrol 2009; 4:1097.</a></li><li><a class="nounderline abstract_t">Chan CT, Floras JS, Miller JA, et al. Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis. Kidney Int 2002; 61:2235.</a></li><li><a class="nounderline abstract_t">Suri R, Depner TA, Blake PG, et al. Adequacy of quotidian hemodialysis. Am J Kidney Dis 2003; 42:42.</a></li><li><a class="nounderline abstract_t">Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant 1998; 13 Suppl 6:10.</a></li><li><a class="nounderline abstract_t">Pierratos A. Daily nocturnal home hemodialysis. Kidney Int 2004; 65:1975.</a></li><li><a class="nounderline abstract_t">National Kidney Foundation. KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update. Am J Kidney Dis 2015; 66:884.</a></li><li><a class="nounderline abstract_t">Mucsi I, Hercz G, Uldall R, et al. Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis. Kidney Int 1998; 53:1399.</a></li><li><a class="nounderline abstract_t">Lockridge RS, Albert J, Anderson H, et al. Nightly Home Hemodialysis: Fifteen Months of Experience in Lynchburg, Virginia. Home Hemodial Int 1999; 3:23.</a></li><li><a class="nounderline abstract_t">Culleton BF, Walsh M, Klarenbach SW, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298:1291.</a></li><li><a class="nounderline abstract_t">Walsh M, Manns BJ, Klarenbach S, et al. The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial. Hemodial Int 2010; 14:174.</a></li><li><a class="nounderline abstract_t">FHN Trial Group, Chertow GM, Levin NW, et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med 2010; 363:2287.</a></li><li><a class="nounderline abstract_t">Daugirdas JT, Chertow GM, Larive B, et al. Effects of frequent hemodialysis on measures of CKD mineral and bone disorder. J Am Soc Nephrol 2012; 23:727.</a></li><li><a class="nounderline abstract_t">Wong B, Collister D, Muneer M, et al. In-Center Nocturnal Hemodialysis Versus Conventional Hemodialysis: A Systematic Review of the Evidence. Am J Kidney Dis 2017; 70:218.</a></li><li><a class="nounderline abstract_t">Rocco MV, Lockridge RS Jr, Beck GJ, et al. The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int 2011; 80:1080.</a></li><li><a class="nounderline abstract_t">Van Eps CL, Jeffries JK, Anderson JA, et al. Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis. Nephrology (Carlton) 2007; 12:224.</a></li><li><a class="nounderline abstract_t">Brunati CCM, Gervasi F, Casati C, et al. Phosphate and Calcium Control in Short Frequent Hemodialysis with the NxStage System One Cycler: Mass Balance Studies and Comparison with Standard Thrice-Weekly Bicarbonate Dialysis. Blood Purif 2018; 45:334.</a></li><li><a class="nounderline abstract_t">Raj DS, Ouwendyk M, Francoeur R, Pierratos A. beta(2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant 2000; 15:58.</a></li><li><a class="nounderline abstract_t">Pauly RP, Gill JS, Rose CL, et al. Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients. Nephrol Dial Transplant 2009; 24:2915.</a></li><li><a class="nounderline abstract_t">Johansen KL, Zhang R, Huang Y, et al. Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study. Kidney Int 2009; 76:984.</a></li><li><a class="nounderline abstract_t">Rocco MV, Daugirdas JT, Greene T, et al. Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial. Am J Kidney Dis 2015; 66:459.</a></li><li><a class="nounderline abstract_t">Nesrallah GE, Lindsay RM, Cuerden MS, et al. Intensive hemodialysis associates with improved survival compared with conventional hemodialysis. J Am Soc Nephrol 2012; 23:696.</a></li><li><a class="nounderline abstract_t">Tennankore KK, Kim SJ, Baer HJ, Chan CT. Survival and hospitalization for intensive home hemodialysis compared with kidney transplantation. J Am Soc Nephrol 2014; 25:2113.</a></li><li><a class="nounderline abstract_t">Mathew A, McLeggon JA, Mehta N, et al. Mortality and Hospitalizations in Intensive Dialysis: A Systematic Review and Meta-Analysis. Can J Kidney Health Dis 2018; 5:2054358117749531.</a></li><li><a class="nounderline abstract_t">Rivara MB, Adams SV, Kuttykrishnan S, et al. Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease. Kidney Int 2016; 90:1312.</a></li><li><a class="nounderline abstract_t">Kuhlmann MK. The eternal (nocturnal) quest for better dialysis outcomes. J Am Soc Nephrol 2012; 23:571.</a></li><li><a class="nounderline abstract_t">Pauly RP, Miller BW. Contextualizing the FHN Nocturnal Trial a Decade Later: How Nocturnal Home Hemodialysis Is Performed Matters to Outcomes. Clin J Am Soc Nephrol 2021; 16:966.</a></li><li><a class="nounderline abstract_t">Mohr PE, Neumann PJ, Franco SJ, et al. The case for daily dialysis: its impact on costs and quality of life. Am J Kidney Dis 2001; 37:777.</a></li><li><a class="nounderline abstract_t">McPhatter LL, Lockridge RS Jr, Albert J, et al. Nightly home hemodialysis: improvement in nutrition and quality of life. Adv Ren Replace Ther 1999; 6:358.</a></li><li><a class="nounderline abstract_t">Manns BJ, Walsh MW, Culleton BF, et al. Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis. Kidney Int 2009; 75:542.</a></li><li><a class="nounderline abstract_t">Jansz TT, Bonenkamp AA, Boereboom FTJ, et al. Health-related quality of life compared between kidney transplantation and nocturnal hemodialysis. PLoS One 2018; 13:e0204405.</a></li><li><a class="nounderline abstract_t">Smyth B, van den Broek-Best O, Hong D, et al. Varying Association of Extended Hours Dialysis with Quality of Life. Clin J Am Soc Nephrol 2019; 14:1751.</a></li><li><a class="nounderline abstract_t">Garg AX, Suri RS, Eggers P, et al. Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis. Kidney Int 2017; 91:746.</a></li><li><a class="nounderline abstract_t">Dumaine CS, Ravani P, Parmar MK, et al. In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease. J Nephrol 2022; 35:245.</a></li><li><a class="nounderline abstract_t">Hall YN, Larive B, Painter P, et al. Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials. Clin J Am Soc Nephrol 2012; 7:782.</a></li><li><a class="nounderline abstract_t">Jablonski KL, Chonchol M. Frequent hemodialysis: a way to improve physical function? Clin J Am Soc Nephrol 2012; 7:707.</a></li><li><a class="nounderline abstract_t">McFarlane PA, Pierratos A, Bayoumi AM, Redelmeier DA. Estimating preference scores in conventional and home nocturnal hemodialysis patients. Clin J Am Soc Nephrol 2007; 2:477.</a></li><li><a class="nounderline abstract_t">Kotanko P, Garg AX, Depner T, et al. Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials. Hemodial Int 2015; 19:386.</a></li><li><a class="nounderline abstract_t">Pierratos A. Nocturnal home haemodialysis: an update on a 5-year experience. Nephrol Dial Transplant 1999; 14:2835.</a></li><li><a class="nounderline abstract_t">Wald R, Yan AT, Perl J, et al. Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis. BMC Nephrol 2012; 13:3.</a></li><li><a class="nounderline abstract_t">Karur GR, Wald R, Goldstein MB, et al. Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling. Nephrol Dial Transplant 2018; 33:1010.</a></li><li><a class="nounderline abstract_t">Wald R, Goldstein MB, Perl J, et al. The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease. Can J Cardiol 2016; 32:369.</a></li><li><a class="nounderline abstract_t">Kang M, Chen J, Liu L, et al. In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study. Front Med (Lausanne) 2022; 9:912764.</a></li><li><a class="nounderline abstract_t">Chan C, Floras JS, Miller JA, Pierratos A. Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure. Nephrol Dial Transplant 2002; 17:1518.</a></li><li><a class="nounderline abstract_t">Jefferies HJ, Virk B, Schiller B, et al. Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning). Clin J Am Soc Nephrol 2011; 6:1326.</a></li><li><a class="nounderline abstract_t">Chan CT, Harvey PJ, Picton P, et al. Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis. Hypertension 2003; 42:925.</a></li><li><a class="nounderline abstract_t">Chan CT, Li SH, Verma S. Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease. Am J Physiol Renal Physiol 2005; 289:F679.</a></li><li><a class="nounderline abstract_t">Yuen DA, Kuliszewski MA, Liao C, et al. Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function. Clin J Am Soc Nephrol 2011; 6:1345.</a></li><li><a class="nounderline abstract_t">Chan CT, Jain V, Picton P, et al. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease. Kidney Int 2005; 68:338.</a></li><li><a class="nounderline abstract_t">Chan CT, Hanly P, Gabor J, et al. Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep. Kidney Int 2004; 65:661.</a></li><li><a class="nounderline abstract_t">Ferrario M, Raimann JG, Larive B, et al. Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients. Blood Purif 2015; 40:99.</a></li><li><a class="nounderline abstract_t">Tsuji H, Larson MG, Venditti FJ Jr, et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94:2850.</a></li><li><a class="nounderline abstract_t">Chan CT, Shen XS, Picton P, Floras J. Nocturnal home hemodialysis improves baroreflex effectiveness index of end-stage renal disease patients. J Hypertens 2008; 26:1795.</a></li><li><a class="nounderline abstract_t">Yuen D, Pierratos A, Richardson RM, Chan CT. The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients. Nephrol Dial Transplant 2006; 21:1407.</a></li><li><a class="nounderline abstract_t">Woods JD, Port FK, Orzol S, et al. Clinical and biochemical correlates of starting "daily" hemodialysis. Kidney Int 1999; 55:2467.</a></li><li><a class="nounderline abstract_t">Ting GO, Kjellstrand C, Freitas T, et al. Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis. Am J Kidney Dis 2003; 42:1020.</a></li><li><a class="nounderline abstract_t">Kooistra MP, Vos J, Koomans HA, Vos PF. Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life. Nephrol Dial Transplant 1998; 13:2853.</a></li><li><a class="nounderline abstract_t">Schwartz DI, Pierratos A, Richardson RM, et al. Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease. Clin Nephrol 2005; 63:202.</a></li><li><a class="nounderline abstract_t">Ornt DB, Larive B, Rastogi A, et al. Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials. Nephrol Dial Transplant 2013; 28:1888.</a></li><li><a class="nounderline abstract_t">Pierratos A, Hercz G, Sherrard DJ, et al. Calcium, Phosphorus Metabolism and Bone Pathology on Long Term Nocturnal Hemodialysis. J Am Soc Nephrol 2001; 12:274A.</a></li><li><a class="nounderline abstract_t">Al-Hejaili F, Kortas C, Leitch R, et al. Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration. J Am Soc Nephrol 2003; 14:2322.</a></li><li><a class="nounderline abstract_t">Toussaint N, Boddington J, Simmonds R, et al. Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis. Hemodial Int 2006; 10:280.</a></li><li><a class="nounderline abstract_t">Kim SJ, Goldstein M, Szabo T, Pierratos A. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis. Am J Kidney Dis 2003; 41:E12.</a></li><li><a class="nounderline abstract_t">Nessim SJ, Jassal SV, Fung SV, Chan CT. Conversion from conventional to nocturnal hemodialysis improves vitamin D levels. Kidney Int 2007; 71:1172.</a></li><li><a class="nounderline abstract_t">Bugeja AL, Chan CT. Improvement in lipid profile by nocturnal hemodialysis in patients with end-stage renal disease. ASAIO J 2004; 50:328.</a></li><li><a class="nounderline abstract_t">Perl J, Unruh ML, Chan CT. Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'? Kidney Int 2006; 70:1687.</a></li><li><a class="nounderline abstract_t">Hanly PJ, Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 2001; 344:102.</a></li><li><a class="nounderline abstract_t">Hanly PJ, Gabor JY, Chan C, Pierratos A. Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis. Am J Kidney Dis 2003; 41:403.</a></li><li><a class="nounderline abstract_t">Ikizler TA, Flakoll PJ, Parker RA, Hakim RM. Amino acid and albumin losses during hemodialysis. Kidney Int 1994; 46:830.</a></li><li><a class="nounderline abstract_t">Spanner E, Suri R, Heidenheim AP, Lindsay RM. The impact of quotidian hemodialysis on nutrition. Am J Kidney Dis 2003; 42:30.</a></li><li><a class="nounderline abstract_t">Kaysen GA, Greene T, Larive B, et al. The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial. Kidney Int 2012; 82:90.</a></li><li><a class="nounderline abstract_t">Majlessi A, Burton JO, March DS. The effect of extended hemodialysis on nutritional parameters: a systematic review. J Nephrol 2022; 35:1985.</a></li><li><a class="nounderline abstract_t">Barua M, Hladunewich M, Keunen J, et al. Successful pregnancies on nocturnal home hemodialysis. Clin J Am Soc Nephrol 2008; 3:392.</a></li><li><a class="nounderline abstract_t">Hladunewich MA, Hou S, Odutayo A, et al. Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison. J Am Soc Nephrol 2014; 25:1103.</a></li><li><a class="nounderline abstract_t">Jassal SV, Devins GM, Chan CT, et al. Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study. Kidney Int 2006; 70:956.</a></li><li><a class="nounderline abstract_t">Kurella Tamura M, Unruh ML, Nissenson AR, et al. Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. Am J Kidney Dis 2013; 61:228.</a></li><li><a class="nounderline abstract_t">McFarlane PA. Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada. Semin Dial 2004; 17:118.</a></li><li><a class="nounderline abstract_t">McFarlane PA, Pierratos A, Redelmeier DA. Cost savings of home nocturnal versus conventional in-center hemodialysis. Kidney Int 2002; 62:2216.</a></li><li><a class="nounderline abstract_t">Kroeker A, Clark WF, Heidenheim AP, et al. An operating cost comparison between conventional and home quotidian hemodialysis. Am J Kidney Dis 2003; 42:49.</a></li><li><a class="nounderline abstract_t">McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int 2003; 64:1004.</a></li><li><a class="nounderline abstract_t">Klarenbach S, Tonelli M, Pauly R, et al. Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial. J Am Soc Nephrol 2014; 25:587.</a></li><li><a class="nounderline abstract_t">McFarlane PA, Bayoumi AM, Pierratos A, Redelmeier DA. The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis. Kidney Int 2006; 69:798.</a></li><li><a class="nounderline abstract_t">Daugirdas JT, Greene T, Rocco MV, et al. Effect of frequent hemodialysis on residual kidney function. Kidney Int 2013; 83:949.</a></li><li><a class="nounderline abstract_t">Suri RS, Larive B, Hall Y, et al. Effects of frequent hemodialysis on perceived caregiver burden in the Frequent Hemodialysis Network trials. Clin J Am Soc Nephrol 2014; 9:936.</a></li><li><a class="nounderline abstract_t">Chan CT, Wallace E, Golper TA, et al. Exploring Barriers and Potential Solutions in Home Dialysis: An NKF-KDOQI Conference Outcomes Report. Am J Kidney Dis 2019; 73:363.</a></li><li><a class="nounderline abstract_t">Chan CT, Collins K, Ditschman EP, et al. Overcoming Barriers for Uptake and Continued Use of Home Dialysis: An NKF-KDOQI Conference Report. Am J Kidney Dis 2020; 75:926.</a></li><li><a class="nounderline abstract_t">Abra G, Schiller B. Public policy and programs - Missing links in growing home dialysis in the United States. Semin Dial 2020; 33:75.</a></li><li><a class="nounderline abstract_t">Malavade TS, Dey A, Chan CT. Nocturnal Hemodialysis: Why Aren't More People Doing It? Adv Chronic Kidney Dis 2021; 28:184.</a></li><li><a class="nounderline abstract_t">Gee PO. Kidney Health Initiative Roadmap for Kidney Replacement Therapy: A Patient's Perspective. Clin J Am Soc Nephrol 2020; 15:585.</a></li><li><a class="nounderline abstract_t">Harris RC, Cahill Z. How the Kidney Health Initiative Catalyzes Innovation in a Dynamic Environment. Clin J Am Soc Nephrol 2020; 15:421.</a></li><li><a class="nounderline abstract_t">Rosner MH, Lew SQ, Conway P, et al. Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT. Clin J Am Soc Nephrol 2017; 12:1900.</a></li><li><a class="nounderline abstract_t">Fowler KJ. Advancing American Kidney Health (AAKH): Catalyst for Investment in Kidney Diseases Clinical Trials and Precision Medicine: An Opportunity to Advance Upstream Interventions and the Importance of Nephrology. Clin J Am Soc Nephrol 2020; 15:1689.</a></li></ol></div><div id="topicVersionRevision">Topic 1959 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://adr.usrds.org/2020/end-stage-renal-disease/5-mortality" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : United States Renal Data System. 2020 Annual Report. Available at: https://adr.usrds.org/2020/end-stage-renal-disease/5-mortality (Accessed on December 02, 2021).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7027040" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8172208" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Effects of dose of dialysis on morbidity and mortality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12490682" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Effect of dialysis dose and membrane flux in maintenance hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11961019" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16609686" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1614043" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Survival as an index of adequacy of dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9719222" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Fifteen years of clinical experience with daily haemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29478056" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Choosing Home Hemodialysis: A Critical Review of Patient Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362905" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Survival with three-times weekly in-center nocturnal versus conventional hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31579998" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Association between patient psychosocial characteristics and receipt of in-center nocturnal hemodialysis among prevalent dialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30255600" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9596084" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Nocturnal hemodialysis: three-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19470659" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Ten years experience of in-center thrice weekly long overnight hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12028465" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830443" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Adequacy of quotidian hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9719197" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : The current place of urea kinetic modelling with respect to different dialysis modalities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15086951" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Daily nocturnal home hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26498416" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9573558" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Control of serum phosphate without any phosphate binders in patients treated with nocturnal hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28455856" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Nightly Home Hemodialysis: Fifteen Months of Experience in Lynchburg, Virginia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17878421" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20041960" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The effects of nocturnal compared with conventional hemodialysis on mineral metabolism: A randomized-controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21091062" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : In-center hemodialysis six times per week versus three times per week.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362907" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28359656" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : In-Center Nocturnal Hemodialysis Versus Conventional Hemodialysis: A Systematic Review of the Evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21775973" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17498116" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Mineral metabolism, bone histomorphometry and vascular calcification in alternate night nocturnal haemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29455202" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Phosphate and Calcium Control in Short Frequent Hemodialysis with the NxStage System One Cycler: Mass Balance Studies and Comparison with Standard Thrice-Weekly Bicarbonate Dialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10607768" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : beta(2)-microglobulin kinetics in nocturnal haemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19584107" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Survival among nocturnal home haemodialysis patients compared to kidney transplant recipients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19692997" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: a USRDS study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25863828" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Long-term Effects of Frequent Nocturnal Hemodialysis on Mortality: The Frequent Hemodialysis Network (FHN) Nocturnal Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22362910" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Intensive hemodialysis associates with improved survival compared with conventional hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24854268" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Survival and hospitalization for intensive home hemodialysis compared with kidney transplantation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29348924" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Mortality and Hospitalizations in Intensive Dialysis: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27555118" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Extended-hours hemodialysis is associated with lower mortality risk in patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22423014" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The eternal (nocturnal) quest for better dialysis outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33184091" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Contextualizing the FHN Nocturnal Trial a Decade Later: How Nocturnal Home Hemodialysis Is Performed Matters to Outcomes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11273878" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : The case for daily dialysis: its impact on costs and quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10543717" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Nightly home hemodialysis: improvement in nutrition and quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19109588" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Nocturnal hemodialysis does not improve overall measures of quality of life compared to conventional hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30235331" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Health-related quality of life compared between kidney transplantation and nocturnal hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31672793" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Varying Association of Extended Hours Dialysis with Quality of Life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28094031" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34050903" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : In-center nocturnal hemodialysis improves health-related quality of life for patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22422538" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Effects of six versus three times per week hemodialysis on physical performance, health, and functioning: Frequent Hemodialysis Network (FHN) randomized trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22516284" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Frequent hemodialysis: a way to improve physical function?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17699454" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Estimating preference scores in conventional and home nocturnal hemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25560227" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Effects of frequent hemodialysis on blood pressure: Results from the randomized frequent hemodialysis network trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10570083" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Nocturnal home haemodialysis: an update on a 5-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22260388" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Regression of left ventricular mass following conversion from conventional hemodialysis to thrice weekly in-centre nocturnal hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28992094" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Association between conversion to in-center nocturnal hemodialysis and right ventricular remodeling.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26386732" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The Association Between Conversion to In-centre Nocturnal Hemodialysis and Left Ventricular Mass Regression in Patients With End-Stage Renal Disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35801203" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : In-center Nocturnal Hemodialysis Reduced the Circulating FGF23, Left Ventricular Hypertrophy, and All-Cause Mortality: A Retrospective Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12147805" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Improvement in ejection fraction by nocturnal haemodialysis in end-stage renal failure patients with coexisting heart failure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21597028" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Frequent hemodialysis schedules are associated with reduced levels of dialysis-induced cardiac injury (myocardial stunning).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14557284" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15928211" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Nocturnal hemodialysis is associated with restoration of impaired endothelial progenitor cell biology in end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21597025" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15954925" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14717939" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Impact of nocturnal hemodialysis on the variability of heart rate and duration of hypoxemia during sleep.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26159747" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Non-Linear Heart Rate Variability Indices in the Frequent Hemodialysis Network Trials of Chronic Hemodialysis Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8941112" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18698214" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Nocturnal home hemodialysis improves baroreflex effectiveness index of end-stage renal disease patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16504981" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10354296" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Clinical and biochemical correlates of starting "daily" hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14582046" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9829490" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Daily home haemodialysis in The Netherlands: effects on metabolic control, haemodynamics, and quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15786821" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Impact of nocturnal home hemodialysis on anemia management in patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23358899" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Impact of frequent hemodialysis on anemia management: results from the Frequent Hemodialysis Network (FHN) Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Calcium, Phosphorus Metabolism and Bone Pathology on Long Term Nocturnal Hemodialysis</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12937309" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Nocturnal but not short hours quotidian hemodialysis requires an elevated dialysate calcium concentration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16805890" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Calcium phosphate metabolism and bone mineral density with nocturnal hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12613005" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17396116" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Conversion from conventional to nocturnal hemodialysis improves vitamin D levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15307542" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Improvement in lipid profile by nocturnal hemodialysis in patients with end-stage renal disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16969388" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Sleep disorders in end-stage renal disease: 'Markers of inadequate dialysis'?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11150360" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12552503" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Daytime sleepiness in patients with CRF: impact of nocturnal hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7996804" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Amino acid and albumin losses during hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830441" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : The impact of quotidian hemodialysis on nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22456602" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The effect of frequent hemodialysis on nutrition and body composition: frequent Hemodialysis Network Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35960430" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : The effect of extended hemodialysis on nutritional parameters: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18308997" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Successful pregnancies on nocturnal home hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24525032" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Intensive hemodialysis associates with improved pregnancy outcomes: a Canadian and United States cohort comparison.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16837916" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Improvements in cognition in patients converting from thrice weekly hemodialysis to nocturnal hemodialysis: a longitudinal pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23149295" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15043613" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Reducing hemodialysis costs: conventional and quotidian home hemodialysis in Canada.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12427148" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Cost savings of home nocturnal versus conventional in-center hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12830444" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : An operating cost comparison between conventional and home quotidian hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12911550" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24231665" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Economic evaluation of frequent home nocturnal hemodialysis based on a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16407887" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23344474" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Effect of frequent hemodialysis on residual kidney function.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24721892" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Effects of frequent hemodialysis on perceived caregiver burden in the Frequent Hemodialysis Network trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30545707" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Exploring Barriers and Potential Solutions in Home Dialysis: An NKF-KDOQI Conference Outcomes Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32057468" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Overcoming Barriers for Uptake and Continued Use of Home Dialysis: An NKF-KDOQI Conference Report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31943408" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Public policy and programs - Missing links in growing home dialysis in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34717866" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Nocturnal Hemodialysis: Why Aren't More People Doing It?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32291271" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Kidney Health Initiative Roadmap for Kidney Replacement Therapy: A Patient's Perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31810991" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : How the Kidney Health Initiative Catalyzes Innovation in a Dynamic Environment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28710094" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32759179" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Advancing American Kidney Health (AAKH): Catalyst for Investment in Kidney Diseases Clinical Trials and Precision Medicine: An Opportunity to Advance Upstream Interventions and the Importance of Nephrology.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
